Imugene Ltd

AU:IMU Australia Biotechnology
Market Cap
$36.20 Million
AU$58.46 Million AUD
Market Cap Rank
#23729 Global
#475 in Australia
Share Price
AU$0.18
Change (1 day)
+0.00%
52-Week Range
AU$0.01 - AU$0.48
All Time High
AU$0.61
About

Imugene Limited, a clinical-stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumours in Australia. Its lead products under development azer-cel, an allogeneic CAR T cell therapy in phase 1 clinical trial targeting relapsed/refractory non-hodgkin lymphoma and b-cell acute lymphoblastic leukemia; CF33 VAXINIA,… Read more

Imugene Ltd (IMU) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of December 2025: -0.620x

Based on the latest financial reports, Imugene Ltd (IMU) has a cash flow conversion efficiency ratio of -0.620x as of December 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-25.97 Million) by net assets (AU$41.87 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Imugene Ltd - Cash Flow Conversion Efficiency Trend (1993–2025)

This chart illustrates how Imugene Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Imugene Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Imugene Ltd ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Imugene Ltd (1993–2025)

The table below shows the annual cash flow conversion efficiency of Imugene Ltd from 1993 to 2025.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$45.03 Million AU$-75.57 Million -1.678x -95.07%
2024-06-30 AU$118.25 Million AU$-101.73 Million -0.860x -447.78%
2023-06-30 AU$189.63 Million AU$-29.78 Million -0.157x +28.98%
2022-06-30 AU$138.70 Million AU$-30.67 Million -0.221x -9.50%
2021-06-30 AU$65.02 Million AU$-13.13 Million -0.202x -19.19%
2020-06-30 AU$59.81 Million AU$-10.13 Million -0.169x +41.54%
2019-06-30 AU$27.29 Million AU$-7.91 Million -0.290x +0.52%
2018-06-30 AU$15.48 Million AU$-4.51 Million -0.291x -24.18%
2017-06-30 AU$11.39 Million AU$-2.67 Million -0.235x +39.56%
2016-06-30 AU$7.86 Million AU$-3.05 Million -0.388x -46.86%
2015-06-30 AU$7.73 Million AU$-2.04 Million -0.264x -55.52%
2014-06-30 AU$6.73 Million AU$-1.14 Million -0.170x +76.58%
2013-06-30 AU$1.89 Million AU$-1.37 Million -0.726x +19.38%
2012-06-30 AU$1.07 Million AU$-965.92K -0.900x -447.17%
2011-06-30 AU$4.21 Million AU$1.09 Million 0.259x +156.39%
2010-06-30 AU$3.79 Million AU$-1.74 Million -0.460x -377.67%
2009-06-30 AU$5.33 Million AU$881.77K 0.166x +160.74%
2008-06-30 AU$4.67 Million AU$-1.27 Million -0.273x +24.77%
2007-06-30 AU$4.70 Million AU$-1.70 Million -0.362x -27.73%
2006-06-30 AU$6.46 Million AU$-1.83 Million -0.284x -50.67%
2005-06-30 AU$8.65 Million AU$-1.63 Million -0.188x +32.68%
2004-06-30 AU$5.43 Million AU$-1.52 Million -0.280x +71.84%
2002-06-30 AU$792.83K AU$-787.36K -0.993x -108.81%
2001-06-30 AU$-226.54K AU$-2.55 Million 11.266x +892.20%
2000-06-30 AU$2.78 Million AU$-3.95 Million -1.422x -147.09%
1999-06-30 AU$6.00 Million AU$-3.45 Million -0.576x -99.40%
1997-06-30 AU$7.45 Million AU$-2.15 Million -0.289x -16.06%
1996-06-30 AU$8.12 Million AU$-2.02 Million -0.249x -58.27%
1995-06-30 AU$10.62 Million AU$-1.67 Million -0.157x -20.81%
1994-06-30 AU$11.19 Million AU$-1.46 Million -0.130x -235.76%
1993-06-30 AU$5.11 Million AU$-198.00K -0.039x --